tiprankstipranks
Advertisement
Advertisement

NRXP Stock Latest News

Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
The FlyPsychedelic: PharmAla enters license agreement with Jupiter Neurosciences
10d ago
LLY
ATAI
NRx Defense Systems Advances DARPA-Backed Depression Trial
PremiumCompany Announcements
NRx Defense Systems Advances DARPA-Backed Depression Trial
11d ago
8K
NRXP
NRx Pharmaceuticals issues response to Kadima statements
PremiumThe Fly
NRx Pharmaceuticals issues response to Kadima statements
1M ago
NRXP
Psychedelic: Definium soars on study results for LSD-based depression treatment
PremiumThe Fly
Psychedelic: Definium soars on study results for LSD-based depression treatment
1M ago
ATAI
CMND
Kadima Neuropsychiatry Institute alleges NRx breached contract
PremiumThe Fly
Kadima Neuropsychiatry Institute alleges NRx breached contract
1M ago
NRXP
ZETA announces treatment of first patient with Zeta TMS Navigation System
PremiumThe FlyZETA announces treatment of first patient with Zeta TMS Navigation System
1M ago
NRXP
Thomas Shrader Reiterates Buy on NRXP, Maintains $25 Price Target on NRX-100/101 FDA and RWE-Driven Upside
Premium
Ratings
Thomas Shrader Reiterates Buy on NRXP, Maintains $25 Price Target on NRX-100/101 FDA and RWE-Driven Upside
1M ago
NRXP
NRx Pharmaceuticals announces FDA grant of expanded access protocol for NRX-101
Premium
The Fly
NRx Pharmaceuticals announces FDA grant of expanded access protocol for NRX-101
1M ago
NRXP
Psychedelic: Optimi Health completes psilocybin export to the UK
PremiumThe Fly
Psychedelic: Optimi Health completes psilocybin export to the UK
2M ago
IXHL
MIRA
NRx Pharmaceuticals Announces $20 Million Public Stock Offering
PremiumCompany Announcements
NRx Pharmaceuticals Announces $20 Million Public Stock Offering
2M ago
8K
NRXP
NRx Pharmaceuticals 5.7M share Spot Secondary priced at $3.50
PremiumThe Fly
NRx Pharmaceuticals 5.7M share Spot Secondary priced at $3.50
2M ago
NRXP
NRx Pharmaceuticals Plans Underwritten Public Stock Offering
PremiumCompany Announcements
NRx Pharmaceuticals Plans Underwritten Public Stock Offering
2M ago
8K
NRXP
NRx Pharmaceuticals announces common stock offering, no amount given
PremiumThe FlyNRx Pharmaceuticals announces common stock offering, no amount given
2M ago
NRXP
Psychedelic: Optimi Health advances natural psilocybin extract
Premium
The Fly
Psychedelic: Optimi Health advances natural psilocybin extract
2M ago
CMND
CMPS
NRX Pharmaceuticals: Regulatory and Commercial De-Risking Supports Unchanged $45 Price Target and Buy Rating
Premium
Ratings
NRX Pharmaceuticals: Regulatory and Commercial De-Risking Supports Unchanged $45 Price Target and Buy Rating
2M ago
NRXP
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
PremiumCompany Announcements
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
2M ago
NRXP
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
PremiumThe Fly
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
2M ago
CMND
CMPS
NRXP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NRXP Earnings this Week: How Will it Perform?
3M ago
NRXP
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
PremiumThe Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
3M ago
ATAI
CMND
NRx Pharmaceuticals initiated with a Buy at Lucid Capital
PremiumThe FlyNRx Pharmaceuticals initiated with a Buy at Lucid Capital
3M ago
NRXP
NRx Pharmaceuticals gets FDA clearance to initiate NRX-101 trial
Premium
The Fly
NRx Pharmaceuticals gets FDA clearance to initiate NRX-101 trial
3M ago
NRXP
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
Premium
The Fly
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
3M ago
JNJ
CMND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >